Regulation of lysyl oxidase by interferon-γ in rat aortic smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 982-988

  Song, Yun Ling ^a   Ford, John W ^a   Gordon, David ^a   Shanley, Charles J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Michigan Heart and Vascular Institute   (United States)

Author keywords

Interferon ; Lysyl oxidase; Smooth muscle cells

Indexed keywords

COLLAGEN; ELASTIN; GAMMA INTERFERON; PROTEIN LYSINE 6 OXIDASE;

ANIMAL CELL; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

EID: 0042392019     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.982     Document Type: Article

References (39)

1. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15: 1145-1151.
2. Libby P. Molecular basis of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
3. Yen HC, Lee FY, Chau LY. Analysis of the T cell receptor V beta repertoire in human aortic aneurysms. Atherosclerosis. 1997;135:29-36.
4. Wills A, Thompson MM, Crowther M, Sayers RD, Bell PR. Pathogenesis of abdominal aortic aneurysm: cellular and biomechanical mechanisms. Eur J Vasc Endovasc Surg. 1996;12:391-400.
5. Diaz A, Jimenez SA. Interferon gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms. Int J Biochem Cell Biol. 1997;29:251-260.
6. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoproteins. Proc Natl Acad Sci USA. 1995;92:3893-3897.
7. Kagan HM, Trackman PC. Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol. 1991;5:206-210.
8. Feres-Filho FJ, Menassa GB, Trackman PC. Regulation of lysyl oxidase by basic fibroblast growth factor (βFGF) in osteoblastic MC3T3-E1 cells. J Biol Chem. 1996;271:6411-6416.
9. Gacheru SN, Thomas KM, Murray SA, Csiszar K, Smith-Mungo LI, Kagan HM. Transcriptional and post-transcriptional regulation of lysyl oxidase expression in vascular smooth muscle cells: effect of transforming growth factor beta (TGF-β1) and serum deprivation. J Cell Biochem. 1997;65:395-407.
10. Trackman PC, Bedell-Hogan D, Tang J, Kagan HM. Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J Biol Chem. 1992;267:8666-8671.
11. Khakoo A, Thomas R, Trompeter R, Duffy P, Price R, Pope FM. Congenital cutis laxa and lysyl oxidase deficiency. Clin Genet. 1997;51: 109-114.
12. Royce PM, Steinmann B. Markedly reduced activity of lysyl oxidase in skin and aorta from a patient with Menke's disease showing unusually severe connective tissue manifestations. Pediatr Res. 1990;28:137-141.
13. Myers BA, Dubick MA, Reynolds RD, Rucker RB. Effect of vitamin B-6 (pyridoxine) deficiency on lung elastin cross-linking in perinatal and weanling rats. Biochem J. 1985;229:153-160.
14. Kagan HM. Biology of the Extracellular Matrix: Regulation of Matrix Accumulation. New York, NY: Academic Press Inc; 1986.
15. Harris ED. Biochemical defect in chick lung resulting from copper deficiency. J Nutr. 1996;116:252-258.
16. Kagan HM, Raghavan J, Hollander W. Changes in aortic lysyl oxidase activity in diet-induced atherosclerosis in the rabbit. Arteriosclerosis. 1981;1:287-291.
17. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
18. Shanley CJ, Gharaee-Kermani M, Sarkar R, Welling TH, Kriegel A, Ford JW, Stanley JC, Phan SH. Transforming growth factor β1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg. 1997;25:446-452.
19. Tan RS, Taniguchi T, Harada H. Identification of the lysyl oxidase gene as a target of the antioncogenic transcription factor (IRF-1) and its possible role in tumor suppression. Cancer Res. 1996;56:2417-2421.
20. Chomczynski P, Sacchi N. Single step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162:156-159.
21. Trackman PC, Pratt AM, Wolanski A, Tang SS, Offner GD, Troxler RF, Kagan HM. Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence. Biochemistry. 1990;29:4863-4870.
22. Indik Z, Abrams WR, Kucich U, Gibson CW, Mecham RP, Rosenbloom J. Production of recombinant human tropoelastin: characterization and demonstration of immunologic and chemotactic activity. Arch Biochem Biophys. 1990;280:80-86.
23. Bedell-Hogan D, Trackman P, Abrams W, Rosenbloom J, Kagan H. Oxidation, cross-linking, and insolubilization of recombinant tropoelastin by purified lysyl oxidase. J Biol Chem. 1993;268:10345-103501.
24. Merscher S, Hanselmann R, Welter C, Dooley S. Nuclear run-off transcription analysis using chemiluminescence detection. Biotechniques. 1994;16:1024-1026.
25. National Center for Health Statistics. Births, marriages, divorces and deaths for January 1997. Monthly Vital Statistics Report. 1997;46:1-18.
26. Ernst CB. Abdominal aortic aneurysm. N Engl J Med. 1993;328: 1167-1172.
27. Osborne-Pellegrin MJ, Farjanel J, Homebeck W. Role of elastase and lysyl oxidase activity in spontaneous rupture of the internal elastic lamina. Arteriosclerosis. 1991;10:1136-1146.
28. Louwrens H, Pearce WH. Aneurysms: new findings and treatments. In: Basic Considerations: Role of Inflammatory Cells in Aortic Aneurysms. Norwalk, Conn: Appleton & Lange; 1994.
29. Deleted in proof.
30. Tamai K, Ishikawa H, Mauviel A, Uitto J. Interferon gamma coordinately upregulates matrix metalloproteinase-1 and matrix metalloproteinase-3 but not tissue inhibitor of metalloproteinase expression in cultured keratinocytes. J Invest Dermatol. 1995;104:384-390.
31. DeMaeyer-Guignard DEJ, DeMaeyer DED. Immunomodulation by inter-feron: recent developments. Interferon. 1985;6:69-96.
32. Southgate KM, Fisher M, Banning AP, Thurston VJ, Baker AH, Fabunmi RP, Groves PH, Davies M, Newby AC. Upregulation of basement membrane-degrading matrix metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res. 1996;79:1177-1187.
33. Jourdan-Le Saux C, Gleyzal C, Raccurt M, Sommer P. Functional analysis of the lysyl oxidase promoter in myofibroblast-like clones of 3T6-fibroblasts. J Cell Biochem. 1997;64:328-341.
34. Csiszar K, Entersz I, Trackman PC, Samid D, Boyd CD. Functional analysis of the promoter and first intron of the human lysyl oxidase gene. Mol Biol Rep. 1996;23:97-108.
35. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and interferon regulator factor 2 (IRF-2), regulation of cell growth and the interferon system. Mol Cell Biol. 1993;13:4531-4538.
36. Jimenez SA, Varga J, Olsen A, Li L, Diaz A, Herbal J, Koch J. Functional analysis of human alpha 1 (I) procollagen gene promoter: differential activity in collagen producing and non-producing cells and response to transforming growth factor beta 1. J Biol Chem. 1994; 269:12684-12691.
37. Varga J, Yufit T, Hitraya E, Brown RR. Control of extracellular matrix degradation by interferon gamma: the tryptophan connection. Adv Exp Med Biol. 1996;398:143-148.
38. Trackman PC, Feres-Filho EJ, Choi YJ. The 3′-untranslated region of rat lysyl oxidase cDNA. Biochim Biophys Acta. 1995;1260:355-360.
39. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, Kagan HM. Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor beta and prostaglandin E2. Am J Respir Cell Mol Biol. 1994;11:751-755.